| Characteristics . | All patients (n = 33) . | Endovascular surgery (n = 19) . | Open surgery (n = 14) . |
|---|---|---|---|
| Demographics | |||
| Age (years) | 63.0 ± 16.2 | 72.5 ± 7.1 | 50.1 ± 16.4 |
| Female gender | 16 (48.5) | 10 (52.6) | 6 (42.9) |
| BMI (kg/m2) | 25.4 ± 5.0 | 25.0 ± 5.1 | 26.0 ± 5.1 |
| Comorbidities | |||
| Smoker | 12 (36.4) | 8 (42.1) | 4 (28.6) |
| Chronic kidney disease | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| Coronary heart disease | 14 (42.4) | 10 (52.6) | 4 (28.6) |
| Diabetes mellitus | 6 (18.2) | 4 (21.1) | 2 (14.3) |
| Hypertension | 23 (69.7) | 15 (78.9) | 8 (57.1) |
| COPD | 13 (39.4) | 11 (57.9) | 2 (14.3) |
| Connective tissue disease | 5 (15.2) | 0 (0) | 5 (35.7) |
| PAD | 4 (12.1) | 4 (21.1) | 0 (0) |
| Maximum aortic diameter (cm) | 6.6 ± 1.3 | 6.4 ± 1.2 | 6.9 ± 1.4 |
| Marker at baseline | |||
| DPP3 (ng/ml) | 15.1 (12.2–18.9) | 14.2 (12.2–17.0) | 16.2 (9.7–22.1) |
| Haemoglobin (mg/dl) | 10.0 ± 1.7 | 9.9 ± 1.7 | 10.2 ± 1.7 |
| Serum creatinine (mg/dl) | 1.1 (0.8–1.4) | 1.2 (0.9–1.5) | 0.9 (0.7–1.1) |
| Operational characteristics | |||
| Operation time (min) | 374 ± 111 | 376 ± 111 | 372 ± 115 |
| ICU ventilation time (min) | 835 (300–1571) | 400 (0–1360) | 1003 (763–3630) |
| Total ventilation time (min) | 1410 (960–2505) | 1080 (628–1947) | 1786 (1316–19441) |
| Stay in the ICU (days) | 4 (3–5) | 3 (2–5) | 5 (4–16) |
| In-hospital stay (days) | 26 (11–35) | 15 (10–35) | 27 (21–34) |
| Blood transfusion (units) | 8 (4–15) | 5 (4–13) | 10 (6–27) |
| Type of TAAA | |||
| TAAA 1 | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| TAAA 2 | 7 (21.2) | 3 (15.8) | 4 (28.6) |
| TAAA 3 | 7 (21.2) | 4 (21.1) | 3 (21.4) |
| TAAA 4 | 10 (30.3) | 8 (42.1) | 2 (14.3) |
| TAAA 5 | 4 (12.1) | 2 (10.5) | 2 (14.3) |
| Characteristics . | All patients (n = 33) . | Endovascular surgery (n = 19) . | Open surgery (n = 14) . |
|---|---|---|---|
| Demographics | |||
| Age (years) | 63.0 ± 16.2 | 72.5 ± 7.1 | 50.1 ± 16.4 |
| Female gender | 16 (48.5) | 10 (52.6) | 6 (42.9) |
| BMI (kg/m2) | 25.4 ± 5.0 | 25.0 ± 5.1 | 26.0 ± 5.1 |
| Comorbidities | |||
| Smoker | 12 (36.4) | 8 (42.1) | 4 (28.6) |
| Chronic kidney disease | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| Coronary heart disease | 14 (42.4) | 10 (52.6) | 4 (28.6) |
| Diabetes mellitus | 6 (18.2) | 4 (21.1) | 2 (14.3) |
| Hypertension | 23 (69.7) | 15 (78.9) | 8 (57.1) |
| COPD | 13 (39.4) | 11 (57.9) | 2 (14.3) |
| Connective tissue disease | 5 (15.2) | 0 (0) | 5 (35.7) |
| PAD | 4 (12.1) | 4 (21.1) | 0 (0) |
| Maximum aortic diameter (cm) | 6.6 ± 1.3 | 6.4 ± 1.2 | 6.9 ± 1.4 |
| Marker at baseline | |||
| DPP3 (ng/ml) | 15.1 (12.2–18.9) | 14.2 (12.2–17.0) | 16.2 (9.7–22.1) |
| Haemoglobin (mg/dl) | 10.0 ± 1.7 | 9.9 ± 1.7 | 10.2 ± 1.7 |
| Serum creatinine (mg/dl) | 1.1 (0.8–1.4) | 1.2 (0.9–1.5) | 0.9 (0.7–1.1) |
| Operational characteristics | |||
| Operation time (min) | 374 ± 111 | 376 ± 111 | 372 ± 115 |
| ICU ventilation time (min) | 835 (300–1571) | 400 (0–1360) | 1003 (763–3630) |
| Total ventilation time (min) | 1410 (960–2505) | 1080 (628–1947) | 1786 (1316–19441) |
| Stay in the ICU (days) | 4 (3–5) | 3 (2–5) | 5 (4–16) |
| In-hospital stay (days) | 26 (11–35) | 15 (10–35) | 27 (21–34) |
| Blood transfusion (units) | 8 (4–15) | 5 (4–13) | 10 (6–27) |
| Type of TAAA | |||
| TAAA 1 | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| TAAA 2 | 7 (21.2) | 3 (15.8) | 4 (28.6) |
| TAAA 3 | 7 (21.2) | 4 (21.1) | 3 (21.4) |
| TAAA 4 | 10 (30.3) | 8 (42.1) | 2 (14.3) |
| TAAA 5 | 4 (12.1) | 2 (10.5) | 2 (14.3) |
Continuous data are reported as the mean ± standard deviation. Categorical data are reported as the absolute and relative frequencies.
BMI: body mass index; COPD: chronic obstructive pulmonary disease; ICU: intensive care unit; PAD: peripheral artery disease; TAAA: thoraco-abdominal aortic aneurysm.
| Characteristics . | All patients (n = 33) . | Endovascular surgery (n = 19) . | Open surgery (n = 14) . |
|---|---|---|---|
| Demographics | |||
| Age (years) | 63.0 ± 16.2 | 72.5 ± 7.1 | 50.1 ± 16.4 |
| Female gender | 16 (48.5) | 10 (52.6) | 6 (42.9) |
| BMI (kg/m2) | 25.4 ± 5.0 | 25.0 ± 5.1 | 26.0 ± 5.1 |
| Comorbidities | |||
| Smoker | 12 (36.4) | 8 (42.1) | 4 (28.6) |
| Chronic kidney disease | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| Coronary heart disease | 14 (42.4) | 10 (52.6) | 4 (28.6) |
| Diabetes mellitus | 6 (18.2) | 4 (21.1) | 2 (14.3) |
| Hypertension | 23 (69.7) | 15 (78.9) | 8 (57.1) |
| COPD | 13 (39.4) | 11 (57.9) | 2 (14.3) |
| Connective tissue disease | 5 (15.2) | 0 (0) | 5 (35.7) |
| PAD | 4 (12.1) | 4 (21.1) | 0 (0) |
| Maximum aortic diameter (cm) | 6.6 ± 1.3 | 6.4 ± 1.2 | 6.9 ± 1.4 |
| Marker at baseline | |||
| DPP3 (ng/ml) | 15.1 (12.2–18.9) | 14.2 (12.2–17.0) | 16.2 (9.7–22.1) |
| Haemoglobin (mg/dl) | 10.0 ± 1.7 | 9.9 ± 1.7 | 10.2 ± 1.7 |
| Serum creatinine (mg/dl) | 1.1 (0.8–1.4) | 1.2 (0.9–1.5) | 0.9 (0.7–1.1) |
| Operational characteristics | |||
| Operation time (min) | 374 ± 111 | 376 ± 111 | 372 ± 115 |
| ICU ventilation time (min) | 835 (300–1571) | 400 (0–1360) | 1003 (763–3630) |
| Total ventilation time (min) | 1410 (960–2505) | 1080 (628–1947) | 1786 (1316–19441) |
| Stay in the ICU (days) | 4 (3–5) | 3 (2–5) | 5 (4–16) |
| In-hospital stay (days) | 26 (11–35) | 15 (10–35) | 27 (21–34) |
| Blood transfusion (units) | 8 (4–15) | 5 (4–13) | 10 (6–27) |
| Type of TAAA | |||
| TAAA 1 | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| TAAA 2 | 7 (21.2) | 3 (15.8) | 4 (28.6) |
| TAAA 3 | 7 (21.2) | 4 (21.1) | 3 (21.4) |
| TAAA 4 | 10 (30.3) | 8 (42.1) | 2 (14.3) |
| TAAA 5 | 4 (12.1) | 2 (10.5) | 2 (14.3) |
| Characteristics . | All patients (n = 33) . | Endovascular surgery (n = 19) . | Open surgery (n = 14) . |
|---|---|---|---|
| Demographics | |||
| Age (years) | 63.0 ± 16.2 | 72.5 ± 7.1 | 50.1 ± 16.4 |
| Female gender | 16 (48.5) | 10 (52.6) | 6 (42.9) |
| BMI (kg/m2) | 25.4 ± 5.0 | 25.0 ± 5.1 | 26.0 ± 5.1 |
| Comorbidities | |||
| Smoker | 12 (36.4) | 8 (42.1) | 4 (28.6) |
| Chronic kidney disease | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| Coronary heart disease | 14 (42.4) | 10 (52.6) | 4 (28.6) |
| Diabetes mellitus | 6 (18.2) | 4 (21.1) | 2 (14.3) |
| Hypertension | 23 (69.7) | 15 (78.9) | 8 (57.1) |
| COPD | 13 (39.4) | 11 (57.9) | 2 (14.3) |
| Connective tissue disease | 5 (15.2) | 0 (0) | 5 (35.7) |
| PAD | 4 (12.1) | 4 (21.1) | 0 (0) |
| Maximum aortic diameter (cm) | 6.6 ± 1.3 | 6.4 ± 1.2 | 6.9 ± 1.4 |
| Marker at baseline | |||
| DPP3 (ng/ml) | 15.1 (12.2–18.9) | 14.2 (12.2–17.0) | 16.2 (9.7–22.1) |
| Haemoglobin (mg/dl) | 10.0 ± 1.7 | 9.9 ± 1.7 | 10.2 ± 1.7 |
| Serum creatinine (mg/dl) | 1.1 (0.8–1.4) | 1.2 (0.9–1.5) | 0.9 (0.7–1.1) |
| Operational characteristics | |||
| Operation time (min) | 374 ± 111 | 376 ± 111 | 372 ± 115 |
| ICU ventilation time (min) | 835 (300–1571) | 400 (0–1360) | 1003 (763–3630) |
| Total ventilation time (min) | 1410 (960–2505) | 1080 (628–1947) | 1786 (1316–19441) |
| Stay in the ICU (days) | 4 (3–5) | 3 (2–5) | 5 (4–16) |
| In-hospital stay (days) | 26 (11–35) | 15 (10–35) | 27 (21–34) |
| Blood transfusion (units) | 8 (4–15) | 5 (4–13) | 10 (6–27) |
| Type of TAAA | |||
| TAAA 1 | 5 (15.2) | 2 (10.5) | 3 (21.4) |
| TAAA 2 | 7 (21.2) | 3 (15.8) | 4 (28.6) |
| TAAA 3 | 7 (21.2) | 4 (21.1) | 3 (21.4) |
| TAAA 4 | 10 (30.3) | 8 (42.1) | 2 (14.3) |
| TAAA 5 | 4 (12.1) | 2 (10.5) | 2 (14.3) |
Continuous data are reported as the mean ± standard deviation. Categorical data are reported as the absolute and relative frequencies.
BMI: body mass index; COPD: chronic obstructive pulmonary disease; ICU: intensive care unit; PAD: peripheral artery disease; TAAA: thoraco-abdominal aortic aneurysm.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
